People

Main Menu

Partners....

has consulted with leading investment funds and financial institutions in Europe and North America for over 20 years in the areas of financial engineering, investment strategy, quantitative analysis and risk management, initially with NatWest and Chase Manhattan

banks and subsequently as the head of quantitative analytics and proprietary trading in a European hedge fund, where he traded US and European equities, fixed income and OTC & exchange traded derivatives.

Dr. Kinlay was the founding partner of the hedge fund Caissa Capital and pioneered the use of advanced econometric models in volatility arbitrage strategies. The models, which provide the basis for the highly successful investment strategies used by Caissa Capital, are made available by Investment Analytics under license. He is the General Partner of the Proteom Fund, which offers sophisticated quantitative strategies using proprietary, state-of-the-art bioengineering technologies.

Dr. Kinlay has lectured at postgraduate level at a number of leading universities including, Carnegie Mellon University in New York, and Oxford, Cambridge and Reading Universities in the UK. He holds postgraduate degrees from the universities of Sheffield, Bristol and London Business School and is currently on the finance faculty at the NYU Stern School of Business.

**Chris Rosevear PhD:**
	Chris Rosevear began his professional career as a corporate finance analyst at AG Becker in New York before moving to Natwest in London. He worked in treasury management at Citibank from 1983-1986 before going on to establish his own consulting firm,
Finance Technique 2000 Ltd. Dr Rosevear has a Doctorate in Economics from the University of Vienna. Jonathan Kinlay and Chris Rosevear initially worked together from 1983 to 1985 at NatWest and subsequently on various consulting projects over the last 20 years.